CT-Guided Transthoracic Needle Biopsy for Evaluation of PD-L1 Expression: Comparison of 22C3 and SP263 Assays

被引：1
|
作者：
Beck, K. [1 ]
Lee, K. Y. [2 ]
Hong, S. J. [3 ]
机构：
[1] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Radiol, Seoul, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Pathol, Seoul, South Korea
[3] Hanyang Univ, Guri Hosp, Coll Med, Radiol, Guri, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
CT-guided biopsy; PD-L1; assay;
D O I：
10.1016/j.jtho.2018.08.421
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA13.01
引用
收藏
页码：S399 / S400
页数：2
相关论文
共 50 条
  • [21] Assessment of concordance among 22C3, SP263, and SP142 immunohistochemistry assay for PD-L1 expression in non-small cell lung cancer.
    Jung, Chi Young
    Kim, Eun Jin
    Sung, Woo Jung
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 41 - 42
  • [22] PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs An Interclone Evaluation by Differently Trained Pathologists
    Munari, Enrico
    Rossi, Giulio
    Zamboni, Giuseppe
    Lunardi, Gianluigi
    Marconi, Marcella
    Sommaggio, Marco
    Netto, George J.
    Hoque, Mohammad O.
    Brunelli, Matteo
    Martignoni, Guido
    Haffner, Michael C.
    Moretta, Francesca
    Pegoraro, Maria C.
    Cavazza, Alberto
    Samogin, Giuseppina
    Furlan, Vanna
    Mariotti, Francesca R.
    Vacca, Paola
    Moretta, Lorenzo
    Bogina, Giuseppe
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (10) : 1384 - 1389
  • [23] Interchangeability between SP263 and 22C3 assays in lung cancer specimens: a reality in daily practice
    Jang, Min Hye
    Baek, Jina
    Shin, Kyeong-Cheol
    Lee, Jang Hoon
    LABORATORY INVESTIGATION, 2019, 99
  • [24] PD-L1 (SP263) staining of fine needle aspirate FFPE samples in NSCLC
    Hayden, D.
    Roland, B.
    Saufkie, K.
    Largo, S.
    Ahmadi, P.
    Vasquez, M.
    Newell, A. E. Hanlon
    Schnittker, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S1113 - S1113
  • [25] PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs
    Park, Yujun
    Koh, Jiwon
    Na, Hee Young
    Kwak, Yoonjin
    Lee, Keun-Wook
    Ahn, Sang-Hoon
    Park, Do Joong
    Kim, Hyung-Ho
    Lee, Hye Seung
    CANCER RESEARCH AND TREATMENT, 2020, 52 (03): : 661 - 670
  • [26] Interchangeability between SP263 and 22C3 assays in lung cancer specimens: a reality in daily practice
    Jang, Min Hye
    Baek, Jina
    Shin, Kyeong-Cheol
    Lee, Jang Hoon
    MODERN PATHOLOGY, 2019, 32
  • [27] PD-L1 (22C3) Expression in Primary and Recurrent Glioblastoma
    Arvanitis, Leonidas
    Chen, Hsiao-Wei
    Louie, Carrie
    D'Apuzzo, Massimo
    Gu, Dongqing
    Yew, Hooi
    Portnow, Jana
    Badie, Benham
    Pillai, Raju
    Aoun, Patricia
    Telatar, Milhan
    Afkhami, Michelle
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1600 - 1600
  • [28] PD-L1 (22C3) Expression in Primary and Recurrent Glioblastoma
    Arvanitis, Leonidas
    Chen, Hsiao-Wei
    Louie, Carrie
    D'Apuzzo, Massimo
    Gu, Dongqing
    Yew, Hooi
    Portnow, Jana
    Badie, Benham
    Pillai, Raju
    Aoun, Patricia
    Telatar, Milhan
    Afkhami, Michelle
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1600 - 1600
  • [29] PD-L1 expression in muscle invasive urothelial carcinoma: Comparison of SP142 and SP263 assay
    Gupta, Gurudutt
    Pasricha, Sunil
    Kamboj, Meenakshi
    Sharma, Anila
    Nayana, N. S.
    Durga, Garima
    Sharma, Anurag
    Rawal, Sudhir
    Meh, Anurag
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2022, 65 (04) : 839 - 843
  • [30] PD-L1 immunohistochemistry comparison of 22C3 and 28-8 assays for gastric cancer
    Narita, Yukiya
    Sasaki, Eiichi
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Kadowaki, Shigenori
    Ito, Seiji
    Yatabe, Yasushi
    Muro, Kei
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (06) : 2696 - +
12345